Download the article in PDF format *** This article explores the recent reclassification of aspartame, a widely used artificial sweetener, by the World Health Organization (WHO) as "Possibly Carcinogenic to Humans." The move has stirred varying responses from regulatory bodies, companies, and media outlets, highlighting the complexities that consumers face in discerning fact from opinion … Continue reading Aspartame Debate: Are Economic Interests Clouding the Truth?
Introduction Recent legal developments in European countries challenge the principle of separate legal personality by extending liability to parent companies for harm caused by the operation of foreign countries. This post focuses on some cases brought before the Netherlands and English courts. These cases involve Nigerian residents and farmers seeking compensation from both Dutch and … Continue reading Towards a socially responsible approach to the duty of care? A comparative approach to the Shell cases in UK and Netherlands
Boots Pharmacy, part of the largest pharmacy chain in Europe and the United States, has once again found itself in the spotlight for yet another dispensing error. On the 14th of December, the incorrect medication was dispensed to a customer at a Basingstoke, Hampshire branch (United Kingdom). The pharmacist on duty filled the patient’s prescription for … Continue reading Understaffing and its threats to patient safety: irresponsible behavior in pharmacy chains
Thalidomide is a synthetic drug developed in 1954 by German pharmaceutical company, Chemie Grünenthal, for use as a sedative in the treatment of insomnia and anxiety. Because of its purported atoxic nature, the use of this “wonder drug” quickly became widespread all over Europe. It was initially used to treat conditions like colds, headaches, and … Continue reading Thalidomide’s Return: A dark shadow still lurks within the pharmaceutical industry